O6-methylguanine-DNA Methyltransferase Promoter Methylation in Patients with Rectal Adenocarcinoma After Chemoradiotherapy Treatment: Clinical Implications
Jaime A. OliverJaime Gómez-MillánJose A. MedinaLaura CabezaGloria PerazzoliCristina Jimenez-LunaKevin DoelloRaúl OrtizPublished in: Balkan medical journal (2019)
O6-methylguanine-DNA methyltransferase methylation status is not correlated with clinicopathologic variables examined in rectal adenocarcinoma selected for chemoradiotherapy, although its role as a biomarker awaits further investigation.